ArticleJournal of molecular histology2026
Nell-1 inhibits osteoclast differentiation and bone resorption in apical periodontitis.
Article in Journal of molecular histology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Apical periodontitis (AP) is characterized by progressive osteoclast-mediated bone destruction. Although Nell-1 may inhibit osteoclast differentiation, the underlying mechanisms and its specific role in AP remain unclear. This study aims to determine the inhibitory effects of Nell-1 on osteoclast differentiation and bone resorption in apical periodontitis. It further explores whether Nell-1 exerts its function through activation of the Wnt/β-catenin signaling pathway. RAW264.7 cells were transfected with Nell-1 to evaluate osteoclast differentiation through TRAP staining, qRT-PCR, and Western blotting. A rat model of apical periodontitis was established, followed by treatment with Nell-1 protein and the Wnt inhibitor IWR-1. The effects on bone resorption were assessed using micro-CT, histology, and TRAP staining. TRAP staining of RAW264.7 cells demonstrated that Nell-1 overexpression inhibited osteoclastogenesis. The effects were reversed by inhibiting the Wnt pathway with IWR-1. Nell-1 was found to substantially reduce bone resorption and the differentiation of osteoclasts in vivo, according to micro-CT and histological evaluations. By activating the Wnt pathway, Nell-1 effectively prevents osteoclast differentiation and bone resorption in apical periodontitis. The findings suggest that Nell-1 may serve as an adjunctive strategy for apical periodontitis.
Indexed as
Identifiers
41989515What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.